The vegan twin trial: an eight-week LDL comparison
Identical twins strengthen the comparison, but do not turn biomarkers into lifetime outcomes.

Illustrative food image, not a photograph of the study intervention.
Why compare twins?
This 2023 trial assigned 22 pairs of identical twins, 44 people in total, to healthy vegan or healthy omnivorous diets, with one twin in each pair following each approach. Follow-up lasted eight weeks. The twin design makes the comparison distinctive, but the study remains a small, single-center dietary experiment. Its primary question concerned LDL cholesterol, not longevity. Reading the design first prevents a compelling family comparison from being mistaken for a much larger study of clinical disease or a guarantee that every participant would respond similarly.
Landry MJ, Ward CP, Cunanan KM, Durand LR et al.. JAMA network open, 2023. PMID 38032644 · DOI
The intervention included support
Meals were delivered during the first four weeks. During weeks five through eight, participants prepared their own diet-appropriate meals and snacks. This sequence is part of the intervention, not a minor logistical detail. It means the result reflects a supported transition followed by a period of self-preparation. Both groups were assigned diets described as healthy, so the comparison should not be retold as vegan eating versus an intentionally poor-quality alternative. Nor can the whole-pattern assignment identify a single food responsible for any observed difference.
Landry MJ, Ward CP, Cunanan KM, Durand LR et al.. JAMA network open, 2023. PMID 38032644 · DOI
Put the LDL estimate first
At eight weeks, the vegan assignment was associated with an LDL difference of minus 13.9 mg/dL relative to the omnivorous assignment, with a 95% confidence interval from minus 25.3 to minus 2.4 mg/dL. Fasting insulin and body weight also favored the vegan group, but these were secondary outcomes. The LDL estimate is a between-group result with uncertainty, not a promise of the same decrease for every reader. It should not be presented as a percentage reduction in heart attacks, which the experiment did not measure.
Landry MJ, Ward CP, Cunanan KM, Durand LR et al.. JAMA network open, 2023. PMID 38032644 · DOI
What eight weeks cannot settle
The trial was open-label, and its duration limits conclusions about sustained adherence and long-term nutrient adequacy. Although vitamin B12 was among the measured secondary outcomes, a short biomarker study cannot certify lifelong adequacy of an unsupplemented dietary pattern. The defensible conclusion is narrower: this supported healthy vegan intervention improved selected cardiometabolic measures relative to the healthy omnivorous intervention over eight weeks. A particular dinner, commercial product, or unsupported version of either diet was not independently tested. Keep those boundaries visible when discussing the result with a clinician.
Landry MJ, Ward CP, Cunanan KM, Durand LR et al.. JAMA network open, 2023. PMID 38032644 · DOI